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The aim of the present study was to evaluate the contribution of peroxisome proliferator-activated receptor (PPAR-β/δ) in animal
model of periodontitis. Male Sprague-Dawley rats were lightly anaesthetized with pentobarbitone (35mg/kg). Sterile, 2-0 black
braided silk thread was placed around the cervix of the lower left ﬁrst molar and knotted medially. Animals received GW0742
(0.3mg/kg, 10% DMSO, i.p. after the ligature placement and daily for eight days). At day 8, the gingivomucosal tissue encircling
the mandibular ﬁrst molar was removed. One the eighth day after placement of the ligature, we evaluated (1) NF-κB expression,
(2) cytokines expression, (3) iNOS expression, (5) the nitration of tyrosine, (6) apoptosis, and (8) the degree of gingivomucosal
tissues injury. Administration of GW0742 signiﬁcantly decreased all of the parameters of inﬂammation as described above. Taken
together, these results demonstrate that GW0742 exerts an anti-inﬂammatory role during experimental periodontitis and is able
to ameliorate the tissue damage.
1.Introduction
Periodontal disease is an inﬂammatory process involving
progressive, episodic loss of the periodontal attachment
apparatus, resulting ultimately in tooth loss in susceptible
patients.
The initiation and progression of periodontal disease de-
pend on the presence of pathogenic bacteria, host response,
and risk factors. These risk factors encompass systemic inﬂu-
ences (such as poorly controlled or uncontrolled diabetes
mellitus), external inﬂuences (such as smoking), intrinsic
factors, and local factors. They include oral hygiene, gender,
race, socioeconomic status, age, systemic health status, use of
medications, smoking, and alcohol and drug abuse.
The inﬂammatory response in periodontal disease
includes the activation of leucocytes, neutrophils, T lympho-
cytes, and plasma cells and the release of antibodies and
chemical inﬂammatory mediators that include cytokines,
chemokines, and C-reactive protein [1].
The initial increased presence of neutrophils at the site is
followed by the release of cytokines by neutrophils and ma-
crophages. Chemical mediators released include tumor
necrosis factor alpha (TNF-α), interleukin-1 (IL-1), and
prostaglandins [2]. The inﬂammatory process includes the
stimulation of ﬁbroblasts by IL-1 and the secretion of ma-
trix metalloproteinases (MMPs, of which collagenase is
the most prominent) by polymorphonuclear neutrophils.
MMPs are responsible for increased collagen breakdown,
and TNF-α is primarily responsible for increased osteoclast
activity resulting in bone resorption [3]. T lymphocytes
secrete receptor activator of nuclear factor kappa-B ligand
(RANKL), which is involved in osteoclast activity and,
therefore, bone resorption [4].2 Mediators of Inﬂammation
The family of transcription factors termed peroxisome
proliferator-activated receptors (PPARs) has recently been
the focus of much interest for their possible role in the
regulation of inﬂammation and immune responses [5].
In particular, PPARα and PPARγ inhibit the activation of
inﬂammatory gene expression and can negatively interfere
with proinﬂammatory transcription factor signalling path-
waysinvascularandinﬂammatorycells.Incontrast,theroles
of PPARβ/δ regulating inﬂammation and immunity are only
just emerging [6].
In general, PPARs must be activated by ligands to
stimulate the expression of their target genes. These ago-
nists can be synthetic molecules, such as drugs used to
treat hypertriglyceridemia and insulin resistance, or natural
physiological ligands, such as fatty acids and eicosanoids
[7]. GW0742, can act as ligand of PPAR-β/δ.I np a r t i c u l a r ,
it has been reported that PPAR-β/δ ligands can inhibit
the expression of various proinﬂammatory cytokines, such
as TNF-α and IL-1β, vascular cell adhesion molecule-1,
platelet-activating factor (PAF) receptor, and cyclooxygenase
(COX)2 generation [8].
In this study, we wanted to investigate whether the mod-
ulation of the inﬂammatory process could limit the devel-
opment of periodontitis analyzing the eﬀects of GW0742 a
synthetic high-aﬃnity ligand for PPAR-β/δ.I np a r t i c u l a r ,t o
gainabetterinsightintothemechanism(s)ofaction,wehave
studied the eﬀect of the PPAR-β/δ agonist on the following
endpoints of the inﬂammatory response: (1) histological
damage,(2)boneloss(radiography),(3)cytokineexpression
(4) nitrotyrosine and inducible nitric oxide synthase (iNOS)
expression, and (5) apoptosis.
2.MaterialsandMethods
2.1. Surgical Procedure. Male Sprague-Dawley rats (280–
400g) were lightly anaesthetized with surgical doses of so-
dium pentobarbitone (35mg/kg). Sterile, 2-0 black braided
silk thread was placed around the cervix of the lower left
ﬁrst molar and knotted medially as previously described
[9]. After the rats had recovered from the anaesthetic, they
were allowed to eat commercial laboratory food and drink
tap water ad libitum. Animal care and protocol were in
compliance with the Italian regulations on protection of
animals used for experimental and other scientiﬁc purposes
(D.M. 116192) as well as with the EEC regulations (O.J.
of E.C. L 358/1 12/18/1986). The animals and the study
protocol wereapproved by the Institutional Animal Care and
User Committee of the University of Messina, Messina, Italy.
2.2. Experimental Groups. Rats were randomly allocated into
the following groups.
(i) Ligature+vehicle group: rats were subjected to liga-
ture-induced periodontitis, and animals received
vehicle i.p. (10% DMSO 1h after the ligature place-
ment and daily treatment for eight days).
(ii) Ligature+GW0742 group: rats were subjected to lig-
ature-induced periodontitis, and animals received
GW0742 (0.3mg/kg, 10% DMSO, i.p. after the
ligature placement and daily for eight days).
At 8 days after the ligature induction of periodontitis,
the rats (N = 10 from each group for each parameter) were
sacriﬁced in order to assess the eﬀects of the compound on
an acute lesion. The right side that is not subject to ligature
was used as control.
In a separate set of experiments was included a dose
responseinordertoevaluatethediﬀerenteﬀectsoftreatment
with GW0742. The following groups Were used for this
purpose.
(i) Ligature+vehicle group: rats were subjected to
ligature-induced periodontitis, and animals received
vehicle i.p. (10% DMSO 1h after the ligature place-
ment and daily treatment for eight days).
(ii) Ligature+GW0742 group: rats were subjected to
ligature-induced periodontitis, and animals received
GW0742 (0.1mg/kg, 10% DMSO, i.p. after the
ligature placement and daily for eight days).
(iii) Ligature+GW0742 group: rats were subjected to
ligature-induced periodontitis, and animals received
GW0742 (0.03mg/kg, 10% DMSO, i.p. after the
ligature placement and daily for eight days).
2.3. Histological Examination. For histopathological exam-
ination, biopsies of gingiva and mucosa tissue from the
buccal and lingual aspect of the teeth were taken 8 days
after the ligature induction of periodontitis. The tissue
slices were ﬁxed in 10% neutral-buﬀered formaldehyde for
5 days, embedded in paraﬃn, and sectioned. The sec-
tions, orientated longitudinally from the teeth crowns, were
stainedwithtrichromeandhaematoxylin-eosinstains.Inthe
gingivomucosal sections stained with trichrome stain, the
total number of inﬁltrating leukocytes (e.g., neutrophils and
mononuclear cells) in cortical interstitial spaces from gingiva
and mucosa tissues was assessed quantitatively by counting
thenumberofinﬁltrating leukocytesin 20high-power ﬁelds.
2.4. Radiography. A radiographic examination at the eighth
day after ligature placement was determinate as previously
described [9]. Mandibles were placed on a radiographic box
at a distance of 90cm from the X-ray source. Radiographic
analysis of normal and ligated mandibles was performed
by X-ray machine (Philips X12 Germany) with a 40kW
exposure for 0.01sec.
2.5. Measurement of Vascular Permeability by the Evans Blue
Extravasations. Vascular permeability was determinate as
previously described [10]. Brieﬂy, animals received the Evans
blue (2.5% dissolved in physiological saline, at a dose of
50mg/kg) via a femoral venous catheter. Extravasated Evans
blue in the excised gingivomucosal tissue samples was
extracted with 1mL formamide for 48h at room temper-
ature for spectrophotometric determination at 620nm and
expressed as μg/g gingivomucosal tissue [10].Mediators of Inﬂammation 3
2.6. Measurement of Alveolar Bone Loss. The distance from
the cementoenamel junction of the ﬁrst lower molars to
the alveolar crest was measured with a modiﬁcation of the
method. Recordings were made along the median axis of
the lingual surface of the mesial and mediolingulal roots of
the lower ﬁrst left and right molars as previously described.
These measurements were performed by an independent
investigator who was unaware of the treatment regimens.
The alveolar bone loss induced by the ligature was expressed
as a diﬀerence between the left and the right sides.
2.7. Myeloperoxidase Activity. Myeloperoxidase activity, an
indicator of polymorphonuclear leukocyte (PMN) accumu-
lation, was determined in gingivomucosal tissue, as previ-
ously described [11]. Myeloperoxidase activity was deﬁned
as the quantity of enzyme degrading 1μmol/min of peroxide
at 37◦C and was expressed in milliunits/g of wet tissue.
2.8. Immunohistochemical Localization of IL-1β, iNOS, Nitro-
tyrosine, Fas-L, Bax, and Bcl-2. At the end of the experiment,
the tissues were ﬁxed in 10% (w/v) PBS-buﬀered formalde-
hyde, and 8μm sections were prepared from paraﬃn-em-
bedded tissues. After deparaﬃnization, endogenous perox-
idase was quenched with 0.3% (v/v) hydrogen peroxide in
60%(v/v)methanolfor30min.Thesectionswerepermeabi-
lized with 0.1% (w/v) Triton X-100 in PBS for 20min. Non-
speciﬁc adsorption was minimized by incubating the section
in 2% (v/v) normal goat serum in PBS for 20min. Endoge-
nousbiotin-oravidin-bindingsiteswereblockedbysequen-
tial incubation for 15min with biotin and avidin (DBA,
Milan, Italy), respectively. Sections were incubated overnight
with antinitrotyrosine rabbit polyclonal antibody (1:500 in
PBS, v/v) or with anti-iNOS antibody (1:500 in PBS, v/v) or
5), with anti-IL-1β polyclonal antibody (Santa Cruz Biotech-
nology, 1:500 in PBS, v/v), with anti-Fas-L polyclonal anti-
body (Santa Cruz Biotechnology, 1:500 in PBS, v/v), with
anti-Bax polyclonal antibody (Santa Cruz Biotechnology,
1:500 in PBS, v/v), or with anti-Bcl-2 polyclonal antibody
(SantaCruzBiotechnology,1:500inPBS,v/v).Sectionswere
washed with PBS and incubated with secondary antibody.
Speciﬁc labelling was detected with a biotin-conjugated goat
anti-rabbit IgG and avidin-biotin peroxidase complex (DBA,
Milan, Italy). In order to conﬁrm that the immunoreactions
for the nitrotyrosine were speciﬁc, some sections were also
incubated with the primary antibody (antinitrotyrosine) in
the presence of excess nitrotyrosine (10mM) to verify the
binding speciﬁcity. To verify the binding speciﬁcity for Bax,
Bcl-2, iNOS, and IL-1β, some sections were also incubated
with only the primary antibody (no secondary) or with only
the secondary antibody (no primary). In these situations, no
positive stainingwasfoundinthesectionsindicating thatthe
immunoreaction was positive in all the experiments carried
out. Immunocytochemistry photographs (n = 5 photos
fromeachsamplecollectedfromallratsineachexperimental
group) were assessed by densitometric analysis by using
OptilabGraftekSoftwareonaMacintoshpersonalcomputer.
2.9. Western Blot Analysis for IkB-α,N F - κB, iNOS, Bax, and
Bcl-2. In brief, gingivomucosal tissues from each rat were
suspended in extraction buﬀer A containing 0.2mM phenyl-
methylsulfonylﬂuoride(PMSF),0.15μMpepstatinA,20μM
leupeptin, and 1μM sodium orthovanadate, homogenized
at the highest setting for 2min, and centrifuged at 1000g
for 10min at 4◦C. Supernatants represented the cytoso-
lic fraction. The pellets, containing enriched nuclei, were
resuspended in buﬀer B containing 1% Triton X-100,
150mM NaCl, 10mM Tris-HCl, pH 7.4, 1mM EGTA, 1mM
EDTA, 0.2mM PMSF, 20M leupeptin, and 0.2mM sodium
orthovanadate. After centrifugation at 15,000g for 30min at
4◦C, the supernatants containing the nuclear protein were
stored at −80◦C for further analysis. Protein concentration
was determined with the by Bio,Rad Protein Assay (Bio-
Rad, Milan, Italy). The levels of IkB-α,i N O S ,B a x ,a n dB c l -
2 were quantiﬁed in cytosolic fraction, while NF-κBp 6 5
levels were quantiﬁed in nuclear fractions. The membranes
of nitrocellulose were blocked with 1x PBS, 5% (w/v) nonfat
dried milk for 40min at room temperature, and they were
subsequently probed with speciﬁc antibodies IkB-α (1:1000;
Santa Cruz Biotechnology, Inc.), anti-iNOS (1:1000 Signal
Transduction), anti-Bax (Santa Cruz Biotechnology, 1:500),
and anti-Bcl-2 (Santa Cruz Biotechnology, 1:500) or anti-
NF-κB p65 (1:1000; Santa Cruz Biotechnology) in 1x PBS,
5% (w/v) nonfat dried milk, and 0.1% Tween 20 at 4◦C
overnight. Membranes were incubated with peroxidase-
conjugated bovine antimouse IgG secondary antibody or
peroxidase-conjugatedgoatanti-rabbitIgG(1:2000;Jackson
Immuno Research Laboratories Inc., West Grove, Pa, USA)
for 1h at room temperature. To ascertain that blots were
loaded with equal amounts of protein lysates, they were also
incubated in the presence of the antibody against β-actin
(1:10,000 Sigma-Aldrich Corp.). The relative expression of
the protein bands of IκB-α (∼37kDa), iNOS (∼130kDa),
NF-κB p65 (65kDa), Bax (∼23kDa), Bcl-2 (∼29kDa) was
quantiﬁed by densitometric scanning of the X-ray ﬁlms with
GS-700 Imaging Densitometer (GS-700, Bio-Rad Labora-
tories, Milan, Italy) and a computer program (Molecular
Analyst, IBM).
2.10. Measurement of Cytokines. Gingivomucosal tissues
were homogenized in PBS containing 2mmol/L of phenyl-
methyl sulfonyl ﬂuoride (Sigma Chemical Co., Milan, Italy)
a n dt i s s u el e v e l so fT N F - α and IL-1β were evaluated. The
assay was carried out by using a colorimetric, commercial kit
(Calbiochem-NovabiochemCorporation,USA)accordingto
the manufacturer instructions. All cytokine determinations
were performed in duplicate serial dilutions. Results are
expressed as pg/100g wet tissue.
2.11. Materials. The primary antibodies directed at Bax
and Bcl-2 were obtained from Santa Cruz Biotechnology,
Inc. (Santa Cruz, Calif, USA). The secondary antibody was
obtained from Jackson ImmunoResearch Laboratories, Inc.
(Jackson, Bar Harbor, Maine, USA). Unless otherwise stated,
all compounds were obtained from Sigma-Aldrich Company
Ltd (Me, Italy). All other chemicals were of the highest com-
mercial grade available. All stock solutions were prepared in
nonpyrogenic saline (0.9% NaCl; Baxter, Italy, UK).4 Mediators of Inﬂammation
2.12. Statistical Evaluation. All values in ﬁgures and text
are expressed as mean ± standard error (S.E.M.) of the
mean of n observations. For the in vivo studies, n rep-
resents the number of animals studied. In the experi-
ments involving histology or immunohistochemistry, the
ﬁgures shown are representative of at least three experi-
ments (histological or immunohistochemistry coloration)
performed on diﬀerent experimental days on the tissue
sections collected from all the animals in each group.
The results were analyzed by one-way ANOVA followed
by a Bonferroni post-hoc test for multiple comparisons.
A P value less than 0.05 was considered signiﬁcant. And
individual group means were then compared with Student’s
unpaired t-test. A P value of less than 0.05 was considered
signiﬁcant.
3. Results
3.1. Eﬀect of GW0742 on Tissue Damage and Bone Resorption.
When compared to gingivomucosal tissues sections taken
fromthecontralateralsideobtainedfromvehicle-treatedrats
(Figure 1(a)), histological examination of gingivomucosal
tissues sections of ligature-operated rats showed oedema,
tissue injury, as well as inﬁltration of the tissue with inﬂam-
matory cells (Figure 1(b)). GW0742 treatment reduced the
degree of gingivomucosal tissues injury (Figure 1(c)). More-
over, Masson’s trichrome stain, which is used to monitor the
increase of collagen ﬁber, was negative in gingivomucosal
tissue sections taken from the contralateral side from vehicle
when compared with gingivomucosal tissue sections of
ligature-operatedrats(Figures1(d)and1(e),resp.).GW0742
treatment reduced the increase of collagen (Figure 1(f)).
shereen.eldeeb:
A radiographic examination of the mandibles, at day 8
after ligature placement, revealed bone matrix resorption in
the lower left ﬁrst molar region after ligation (Figure 1(g)).
There was no evidence of pathology in the right ﬁrst
molar (data not shown). GW0742 markedly reduced the
degree of bone resorption in the lower left ﬁrst molar
region after ligation (Figure 1(h)). A signiﬁcant alveolar
bone loss between the lower ﬁrst left molar and the right
ﬁrst molars induced by the left-side ligature was observed
in vehicle-treated rats. GW0742 treatment resulted in a
signiﬁcant inhibition of alveolar bone loss after ligation
(Figure 1(i)).Datarepresentthemean±S.E.M.for20counts
obtained from the gingivomucosal tissue of each treatment
group ∗P<0.01 versus nonligated. ◦P<0.01 versus
ligated.
3.2. Eﬀects of GW0742 Treatment on NF-κBA c t i v a t i o ni n
Periodontitis. We evaluated IκB-α degradation by Western
Blot analysis to investigate the cellular mechanisms by which
treatment with GW0742 may attenuate the development of
periodontitis. A basal level of IκB-α was detected in the
gingivomucosal tissues from the contralateral side obtained
from vehicle-treated rats, whereas in the gingivomucosal
tissuesfromligature-operatedratsIκB-αlevelsweresubstan-
tially reduced (Figures 2(a) and 2(b)). GW0742 treatment
prevented the ligature-induced IκB-α degradations in the
gingivomucosal tissues at eight days following ligation
(Figures 2(a) and 2(b)). In addition, periodontitis caused a
signiﬁcant increase in the NF-κB p65 levels in the nuclear
fractions from of gingivomucosal tissues from operated rats
(Figures 2(c) and 2(d)) compared to the gingivomucosal
tissues from the contralateral side (Figures 2(c) and 2(d)).
GW0742treatmentsigniﬁcantlypreventedtheperiodontitis-
mediated NF-κB p65 expression (Figures 2(c) and 2(d)).
3.3. Eﬀects of GW0742 on Cytokines Secretion, Plasma Extrav-
asations, and Neutrophils Inﬁltration in Periodontitis. To
test whether GW0742 modulates the inﬂammatory process
throughtheregulationofsecretionofproinﬂammatorycyto-
kines, we analyzed the gingivomucosal levels of the proin-
ﬂammatory cytokines TNF-α and IL-1β. A substantial in-
crease in TNF-α and IL-1β formation was observed in
gingivomucosal tissues at eight days following ligation, when
compared with the gingivomucosal tissues from the contra-
lateralside(Figures3(a)and3(b),resp .).Incontrast,asignif-
icant inhibition of these cytokines was detected in GW0742-
administered animals. (Figures 3(a) and 3(b), resp.).
As regards we analyzed, by immunohistochemical anal-
ysis, levels of IL-1β. Immunohistochemical analysis of gin-
givomucosal tissues from the contralateral side obtained
from vehicle-treated rats did not reveal any immunoreactiv-
ity for IL-1β (data not shown). In contrast, 8 days following
ligation, positive staining for IL-1β was found in the gin-
givomucosal tissues from ligature operated rats (Figure 3(c)
see densitometry analysis Figure 3(e)). GW0742 treatment
signiﬁcantly reduced the degree of positive staining for
this proinﬂammatory cytokine IL-1β (Figure 3(d) see den-
sitometry analysis Figure 3(e)). Myeloperoxidase activity
was significantly elevated at eight days after the ligature
(Figure 3(f)), and GW0742 treatment signiﬁcantly reduced
these levels (Figure 3(f)). No signiﬁcant changes of mye-
loperoxidase activity were observed in the gingivomucosal
tissues from the contralateral side (Figure 3(f)). Quantiﬁ-
cation of inﬁltrating polymorphonuclear cell into gingivo-
mucosal tissue showed that there were only a minimal
number of polymorphonuclear cells in tissue from the
contralateral side (Figure 3(g)). However, a large number
of inﬁltrating polymorphonuclear cell were observed in
the gingivomucosal tissue of ligated rats (Figure 3(g)).
GW0742 administration signiﬁcantly reduced the numbers
of polymorphonuclear cell inﬁltrating into gingivomucosal
tissue (Figure 3(g)).
Moreover, before the measurement of the Evans blue ex-
travasations, mean arterial pressure of vehicle-treated and
GW0742-treated animals was recorded. In agreement with
previous studies [12], GW0742 treatment did not aﬀect
mean arterial blood pressure (vehicle treated: 128 +
6mmHg; N = 10 and GW0742 treated: 125 + 7mmHg;
N = 10). Ligation signiﬁcantly increased the Evans blue
extravasations in gingivomucosal tissue compared to the
contralateral side (Figure 3(h)). GW0742 treatment pre-
v e n t e dt h i si n c r e a s ei nt h eE v a n sb l u ee x t r a v a s a t i o n sb u td i d
not change the Evans blue content of the contralateral side
(Figure 3(h)).Mediators of Inﬂammation 5
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Figure 1: Eﬀect of GW0742 on tissue damage and bone resorption. Inﬂammatory cells inﬁltration and edema were observed in
gingivomucosal section from ligated rats (b) when compared with gingivomucosal tissue section taken from contralateral side (a).
Signiﬁcantlylessedemaandinﬂammatorycellinﬁltrationwasobservedingingivomucosalsectionsfromligature-treatedratswhichhadbeen
treated with GW0742 (c). Moreover, Masson’s trichrome stain was negative in gingivomucosal tissue sections taken from the contralateral
side of vehicle when compared with gingivomucosal tissues sections of ligature-operated rats (d, e, resp.). GW0742 treatment reduced the
increase of collagen (f). The alveolar bone from ligated rats demonstrated alveolar bone resorption (g). GW0742 treatment suppressed
alveolar bone resorption (h). A signiﬁcant increase in the distance between cementoenamel injunction and alveolar crest at mediolingulal
root of the ﬁrst molar was observed in ligature-treated rats (i). GW0742 treatment signiﬁcantly reduced the increase in the distance between
cementoenamel injunction and alveolar crest (i). Figures are representative of at least 3 experiments performed on diﬀerent experimental
days. The tissue sections, orientated longitudinally from the teeth crown, were stained with trichrome stain. Data represent 20 counts
obtained from the gingivomucosal tissue of each treatment group. ∗P<0.01 versus nonligated. ◦P<0.01 versus ligated.
3.4. Eﬀects of GW0742 on iNOS Expression and Nitroty-
rosine Formation in Periodontitis. Sections of gingivomu-
cosal tissue from the contralateral side did not reveal any
immunoreactivity for iNOS and nitrotyrosine, within the
normal architecture (data not shown). At 8 days following
ligation, positive staining for iNOS (Figure 4(a), see densit-
ometry analysis Figure 4(e)) and nitrotyrosine (Figure 4(c),
see densitometry analysis Figure 4(e)), was found in the
gingivomucosal tissues from ligature-operated rats. GW0742
treatment abolished the staining for iNOS and nitrotyrosine
(Figures 4(b) and 4(d); resp., see densitometry analysis
Figure 4(e)). Moreover, levels of iNOS in gingivomucosal
tissues were also evaluated by western blot analysis. iNOS
levels were substantially increased in the gingivomucosal6 Mediators of Inﬂammation
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Figure 2: Eﬀects of GW0742 treatment on NF-κB activation in periodontitis. A basal level of IκB-α was detected in the gingivomucosal
tissue sections taken from the contralateral side (a, b). IκB-α levels were substantially reduced (a, b) in the gingivomucosal tissues from
ligature-operated rats. GW0742 treatment prevented IκB-α degradation, (a, b). Periodontitis caused a signiﬁcant increase in the NF-κBp 6 5
levels in the gingivomucosal tissues from operated rats (c, d). GW0742 treatment signiﬁcantly prevented NF-κB p65 expression (c, d). A
representative blot of lysates obtained from 5 animals per group is shown and densitometry analysis of all animals is reported. The results
in (b, d) are expressed as mean±S.E.M. from n = 5/6 gingivomucosal tissues for each group. ∗P<0.01 versus nonligated group. ◦P<0.01
versus ligated group.
tissues of saline-treated rats (Figures 4(f) and 4(g)). In
contrast, GW0742 treatment prevented the periodontitis-
mediated iNOS expression (Figures 4(f) and 4(g)).
3.5. Eﬀects of GW0742 on Bax and Bcl-2 Expression. To test
whether PPAR-β/δ gene plays a role on apoptosis in gingivo-
mucosal tissues after ligature placement, we measured Fas-L,
Bax, and Bcl-2 expression by immunohistochemical analysis
at eight days following ligation.
No positive staining for Bax and Fas-L was observed in
gingivomucosal tissues from the contralateral side obtained
from vehicle-treated rats (data not shown). Immunohisto-
chemistry for Fas-L and Bax showed positive staining in the
gingivomucosal sections after ligature (Figure 5(a) and 5(e),
resp.). The degree of positive staining for Fas-L and Bax
weremarkedlyreducedinGW0742-treatedrats(Figures5(b)
and 5(f), resp.). To detect Bcl-2 expression, whole sample
from gingivomucosal tissues of rats were also analyzed
by immunohistochemical analysis. In immunohistochemical
assay, the degree of positive staining for Bcl-2 was markedly
reduced in gingivomucosal sections obtained after ligature
(Figure 5(c)). The reduction of Bcl-2 expression caused
by ligature was signiﬁcantly attenuated in gingivomucosal
sections from GW0742-treated rats (Figure 5(d)). A normal
basal staining for Bcl-2 was observed in gingivomucosal
tissues from the contralateral side obtained from vehicle-
treated rats (data not shown).
Moreover, the appearance of Bax and Bcl-2 in homo-
genates of gingivomucosal tissues was investigated by West-
ern blot analysis. A basal level of Bax was detectable in the
homogenized gingivomucosal tissues from sham-operated
animals (Figures 5(g) and 5(h)). Bax levels were substantially
increased in the gingivomucosal tissues of saline-treated rats
(Figures 5(g) and 5(h)). In contrast, GW0742 treatment
prevented the periodontitis-mediated Bax expression (Fig-
ures 5(g) and 5(h)). A low basal level of Bcl-2 expression
was detected in gingivomucosal homogenates from tissue- of
sham-operated rats (Figures 5(i) and 5(j)). The expression of
Bcl-2wassigniﬁcantlydiminishedinwholeextractsobtained
from gingivomucosal tissues of vehicle-treated rats after liga-
ture (Figures 5(i) and 5(j)). Treatment of rats with GW0742
signiﬁcantly reduced the ligature-induced inhibition of Bcl-2
expression.
3.6.EﬀectsofGW0742DoseResponseonInﬂammatoryParam-
eters. To test whether diﬀerent doses of GW0742 modulate
the inﬂammatory process, we also analyzed the gingivo-
mucosal levels of proinﬂammatory cytokine and neutrophil
inﬁltration at eight days following ligation. A substantial
increase in TNF-α,I L - 1 β formation and MPO activity was
observed in gingivomucosal tissues at eight days following
ligation, when compared with the gingivomucosal tissues
from the contralateral side (Figures 6(a), 6(b),a n d6(c),
resp.). Administration of GW0742 at diﬀerent doses (0,03Mediators of Inﬂammation 7
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and 0,1mg/kg) did not reduced TNF-α,I L - 1 β formation
and MPO activity in gingivomucosal tissues at eight days
following ligation (Figures 6(a), 6(b),a n d6(c),r e s p . ) .
4. Discussion
In this study, we focused our attention on a potential anti-
inﬂammatory activity role of PPAR β/δ agonistfortreatment
of periodontal disease. We demonstrate that a PPAR β/δ ago-
nist, GW0742, exerts beneﬁcial eﬀects in a rat model of peri-
odontitis attenuating (1) NF-κBe x p r e s s i o n ,( 2 )p r o i n ﬂ a m -
matory cytokines production, (3) iNOS and nitrotyrosine
expression, (4) apoptosis, and (5) the degree of gingivomu-
cosal tissues in rats subjected to ligature-induced periodon-
titis. All of these ﬁndings support the view that PPAR β/δ
has a detrimental role in the attenuation of injury associatedMediators of Inﬂammation 9
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with periodontitis in rats. It has been known that PPAR β/δ
agonists have anti-inﬂammatory characteristics [13].
Most of the anti-inﬂammatory eﬀects of PPARs can
probably be explained in this way. It has been known today
thatactivationofPPARs(byeitherendogenousorexogenous
ligands) inhibits the activation of the transcription factors
includingnuclearfactorκB(NF -κB),activatorprotein1(AP-
1),signaltransducersandactivatorsoftranscription(STATs),
and the nuclear factor of activated T cells (NFAT) [14].
This subsequently attenuates the formation of cytokines,
chemokines, and adhesion molecules and, therefore, reduces
excessive inﬂammation and tissue injury.10 Mediators of Inﬂammation
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Figure 6: Eﬀects of GW0742 dose response on inﬂammatory parameters. A substantial increase in TNF-α,I L - 1 β formation and MPO
activity was observed in gingivomucosal tissues at eight days following ligation, when compared with the gingivomucosal tissues from the
contralateral side (Figures 6(a), 6(b),a n d6(c), resp.). Administration of GW0742 at diﬀerent doses (0,03 and 0,1mg/kg) did not reduce
TNF-α,I L - 1 β formation and MPO activity in gingivomucosal tissues at eight days following ligation (Figures 6(a), 6(b),a n d6(c),r e s p . ) .
In this work, we conﬁrm that PPAR-β/δ increases IkB-α
expression, preventing nuclear p50/p65 NF-κB translocation
and arresting their nuclear transcriptional activity including
nitric oxide synthase expression (iNOS), TNF-α,a n dI L - 1 β
to name but a few.
During the initiation and progression of periodontal dis-
ease, inﬂammatory cytokines are considered to play impor-
tant roles. Several reports have suggested a relationship be-
tween the progression of periodontitis and the expression of
interleukin-1 (IL-1), IL-6, IL-8, and tumor necrosis factor-
α in gingival tissues [15] .T h e r ei sg o o de v i d e n c et h a tI L -
1β helps to propagate the extension of a local or systemic
inﬂammatory process [16]. Interestingly, the levels of this
proinﬂammatory cytokine were signiﬁcantly lower in the
ligated rats that were treated with GW0742.
Our study also conﬁrmed earlier ﬁndings, that one of
the characteristic signs of inﬂammation, the Evans blue
extravasation, was higher on the ligated side on the eighth
day than on the opposite side. In addition, we also report
in the present study that ligature-induced periodontitis in
the rat results in a signiﬁcant inﬁltration of inﬂammatory
cellsinthegingivomucosaltissues,andwealsodemonstrated
that treatment with GW0742 reduces this inﬂammatory cells
inﬁltration as assessed by myeloperoxidase.Mediators of Inﬂammation 11
Neutrophils and macrophages are critical in host defense
against bacterial infections. When phagocytic cell number of
function is compromised, disease progression and severity
are markedly increased. Periodontal disease is a common
sequelae associated with altered phagocytic response.
Neutrophilsareimportantinperiodontaldiseasebecause
they control the periodontal microecology prior to involve-
ment of chronic inﬂammatory cells. In contrast, monocytes
and lymphocytes dictate tissue responses in periodontal
microecology. It may be proposed simplistically that either
hypofunction or altered PMN function or hyperfunction of
monocytes/lymphocytes may result in increased susceptibil-
ity to periodontal disease. Also, though they are essential
for host defense, these phagocytic cells can cause some
damage to healthy tissues’ Bystander eﬀect. The junctional
epithelium is particularly at risk of such damage because
PMNs secrete their enzymes and toxins on bacteria which
adhere to it, damaging epithelial cell underneath.
Furthermore, we found that enhanced formation of NO
byiNOSmaycontributetotheinﬂammatoryprocess.Several
studies also support the conclusion that NO from iNOS has
detrimental eﬀects such as a cytotoxic action toward the host
tissues, alveolar bone resorption due to the stimulating eﬀect
ofnitric oxide onthe activityoftheosteoclasts [9,17].Inthis
study,wedeterminedtheexpressionand,thus,theformation
of iNOS, through the technique of immunohistochemistry;
our results demonstrate that GW0742 treatment attenuates
the expression of iNOS in periodontal tissue. Thus, the
reduction of the expression of iNOS, by PPAR β/δ agonist,
may contribute to the attenuation by this agent of the
formation of nitrotyrosine in the periodontal tissues from
ligature-treated rats. Increased nitrotyrosine staining is an
indicator of “increased nitrosative stress.”
Apoptosis, or programmed cell death, is a form of phys-
iological cell death [18]. It is increased or decreased in the
presence of infection, inﬂammation, or tissue remodeling.
Previous studies have suggested that apoptosis is involved in
the pathogenesis of inﬂammatory periodontal disease [19].
As apoptosis is an exceedingly complex process involving a
large variety of signaling molecules; we have focused our
attention on a few selective major players. From the re-
sults, we identiﬁed proapoptotic transcriptional changes,
including upregulation of proapoptotic Bax and downreg-
ulation of antiapoptotic Bcl-2, using a western blot and
immunohistochemistry assay. This is the ﬁrst study to show
that treatment with GW0742 in periodontitis inhibits and
prevents the loss of the antiapoptotic pathway and, also,
reduces the activation of the proapoptotic pathway by an, as
yet, unidentiﬁed mechanism.
5. Conclusion
In conclusion, this study provides the ﬁrst evidence that
GW0742 causes a substantial reduction of ligature-induced
periodontitis in the rat. The mechanisms underlying the
protective properties of GW0742 involve modulation of
transcription factors and consequent altered gene expres-
sion, resulting in downregulation of inﬂammation. These
ﬁndings provide support that PPAR β/δ agonist, GW0742,
may provide a promising approach for the treatment of
periodontitis, reducing plasma extravasation and the degree
of bone resorption during periodontitis.
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